Feasibility and Acceptability of HCV Treatment in Pregnancy

Recruiting now

Conditions studied: Hepatitis C, Pregnancy Complications

In brief

Pregnant adults over the age of 18 who are seen in the Washington University obstetrics and gynecology, maternal fetal medicine or infectious diseases clinic or admitted to BJH with hepatitis C virus infection who have a history of past or current drug use Participant Duration: Approximately 1 year. Aims: Aim 1 - Evaluate adherence and treatment completion rates when glecaprevir-pibrentasvir is started during pregnancy for women who use drugs. Aim 2 - Evaluate patient experience with hepatitis C virus treatment during pregnancy.

Key facts

Study ID

NCT06367465

Run by

Washington University School of Medicine

People needed

50

Starts

2024-02-01

Expected to finish

2026-12-28

Last updated by the study team

2026-06-09

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female patients ≥ 18 years old, pregnant at the time of study intake, diagnosed with hepatitis c virus infection and a history of past or current drug use.

Where it is running

• Barnes Jewish Hospital — St Louis, Missouri, United States (enrolling)
• Washington Univeristy — St Louis, Missouri, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.